Berman Capital Advisors’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$36K Buy
1,175
+353
+43% +$9.97K 0.01% 799
2021
Q2
$20K Buy
+822
New +$18.3K ﹤0.01% 901
2020
Q4
Sell
-73
Closed -$1K 1653
2020
Q3
$1K Buy
+73
New +$1.33K ﹤0.01% 1394
2020
Q2
Sell
-19
Closed 1591
2020
Q1
$0 Sell
19
-137
-88% -$2.45K ﹤0.01% 1448
2019
Q4
$3K Sell
156
-253
-62% -$5.03K ﹤0.01% 1075
2019
Q3
$7K Buy
409
+378
+1,219% +$8.22K ﹤0.01% 821
2019
Q2
$0 Buy
+31
New +$850 ﹤0.01% 1456

Other funds holding ALKS

Berman Capital Advisors's ALKS Position: Q3 2021 in Review

Berman Capital Advisors increased its Alkermes (ALKS) stake by 43% in Q3 2021, buying an estimated $9.97K and bringing the position to 1,175 shares worth $36K. The position accounts for 0.01% of the portfolio, ranked #799.

Berman Capital Advisors first reported a position in ALKS in Q2 2019 and has held it in 7 quarters since. 224 funds tracked by Wall St. Rank hold ALKS as of Q3 2021.

  • Berman Capital Advisors held 1,175 shares of Alkermes worth $36K as of Q3 2021.
  • Berman Capital Advisors bought 353 Alkermes shares in Q3 2021, an estimated $9.97K.
  • Alkermes made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #799 holding.
  • Berman Capital Advisors first reported a position in Alkermes in Q2 2019 and has held it in 7 quarters since.
  • 224 funds tracked by Wall St. Rank held Alkermes as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.